Literature DB >> 1839136

Inhibition of the tocolytic activity of atrial natriuretic factor by progesterone and potentiation by progesterone receptor antagonist RU486 in rats.

W Potvin1, S Mulay, D R Varma.   

Abstract

1. The influence of progesterone on the activity of atrial natriuretic factor (ANF) on rat myometrial motor activity was determined in vitro. 2. ANF inhibited the tension development by myometrium from cycling or oestrogen-treated rats in a dose-dependent manner; maximal inhibition was 100%. 3. Injections of progesterone into rats inhibited the tocolytic activity of ANF in a dose and time-dependent manner. The tocolytic effects of ANF were completely abolished by 3 daily injections of 1 mg kg-1 progesterone. 4. Pregnancy-related increase in plasma progesterone was accompanied by a corresponding decrease in the tocolytic effects of ANF; myometria from gestational day 10 to 21 were completely refractory and those from earlier gestational age and immediate postpartum were responsive to ANF to varying degrees. 5. Treatment of pregnant rats with the progesterone antagonist, RU486, caused abortions and vaginal bleeding, decreased plasma progesterone concentrations and restored the tocolytic activity of ANF. Tocolytic activity of ANF on virgin rat myometria was potentiated by RU486. 6. Progesterone also inhibited the effects of ANF on myometria from ovariectomized rats. 7. Tocolytic activity of isoprenaline was not modified by progesterone, pregnancy, RU486 or ovariectomy. 8. It is concluded that progesterone antagonizes myometrial effects of ANF by an oestrogen-independent mechanism and the pregnancy-induced refractoriness to the tocolytic effects of ANF is caused by progesterone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839136      PMCID: PMC1908542          DOI: 10.1111/j.1476-5381.1991.tb12439.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Atrial natriuretic peptide receptors in normal human placentas.

Authors:  C G Hatjis; D M Grogan
Journal:  Am J Obstet Gynecol       Date:  1988-09       Impact factor: 8.661

2.  Atrial natriuretic peptide and arginine vasopressin in pregnancy and pregnancy-induced hypertension.

Authors:  A N Elias; N D Vaziri; M R Pandian; D R Powers; E Domurat
Journal:  Nephron       Date:  1988       Impact factor: 2.847

3.  Plasma atrial natriuretic peptide (ANP) in late pregnancy and puerperium.

Authors:  E A Steegers; P R Hein; A C Tan; E A Groeneveld; H W Jongsma; T J Benraad
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1987-11       Impact factor: 2.435

4.  Localization of binding sites for ANF in the rat mammary gland.

Authors:  G Pelletier
Journal:  Peptides       Date:  1988 May-Jun       Impact factor: 3.750

5.  Changes in placental atrial natriuretic peptide receptors associated with severe toxemia of pregnancy.

Authors:  C G Hatjis; D M Grogan
Journal:  Placenta       Date:  1989 Mar-Apr       Impact factor: 3.481

6.  Effect of atrial natriuretic factor in rat pregnancy.

Authors:  C G Kristensen; Y Nakagawa; F L Coe; M D Lindheimer
Journal:  Am J Physiol       Date:  1986-04

7.  Atrial natriuretic peptide concentrations in pre-eclampsia.

Authors:  J K Thomsen; T L Storm; G Thamsborg; M de Nully; B Bødker; S Skouby
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

8.  Changes in concentration of human atrial natriuretic peptide in normal pregnancy and toxaemia.

Authors:  Y Otsuki; E Okamoto; I Iwata; E Nishino; N Mitsuda; M Mori; T Takagi; N Sugita; O Tanizawa
Journal:  J Endocrinol       Date:  1987-08       Impact factor: 4.286

9.  Atrial natriuretic factor in maternal and fetal sheep.

Authors:  C Y Cheung; D M Gibbs; R A Brace
Journal:  Am J Physiol       Date:  1987-02

10.  The effect of galanin, CGRP and ANP on spontaneous smooth muscle activity of rat uterus.

Authors:  T Bek; B Ottesen; J Fahrenkrug
Journal:  Peptides       Date:  1988 May-Jun       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.